0.897
0.0069 (0.78%)
0.0069 (0.78%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.4222
High
2.32
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0069 | 0.78% | 0.897 | 19:55:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8827 | 0.8706 | 0.9389 | 0.8788 | 0.8901 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.89 | 0.897 | 0.007 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,625 | 2,398,609 | $ 0.9021193 | $ 2,163,831 | 4,358,677 | 0.4222 - 2.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:46:37 | formt | 100 | $ 0.897 | USD |
Regulus Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 67.21M | 74.92M | 60.93M | $ 10.01M | $ -9.16M | -0.50 | -2.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 74.25k | 4.70% |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.0525 | 1.10 | 0.8706 | 0.9689797 | 5,303,440 | -0.1555 | -14.77% |
| 1 Month | 0.97 | 1.48 | 0.8706 | 1.04 | 6,166,456 | -0.073 | -7.53% |
| 3 Months | 1.51 | 1.63 | 0.8156 | 1.09 | 2,827,999 | -0.613 | -40.6% |
| 6 Months | 1.20 | 2.32 | 0.8156 | 1.41 | 3,018,783 | -0.303 | -25.25% |
| 1 Year | 0.92 | 2.32 | 0.4222 | 1.20 | 2,345,347 | -0.023 | -2.5% |
| 3 Years | 8.40 | 8.9916 | 0.4005 | 1.41 | 1,129,943 | -7.50 | -89.32% |
| 5 Years | 69.48 | 71.436 | 0.4005 | 6.50 | 950,529 | -68.58 | -98.71% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
